174 related articles for article (PubMed ID: 2427453)
1. Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide.
Stoll BJ; Pollack M; Young LS; Koles N; Gascon R; Pier GB
Infect Immun; 1986 Sep; 53(3):656-62. PubMed ID: 2427453
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of a human monoclonal antibody that recognizes epitopes shared by Pseudomonas aeruginosa immunotype 1, 3, 4, and 6 lipopolysaccharides.
Lang AB; Fürer E; Larrick JW; Cryz SJ
Infect Immun; 1989 Dec; 57(12):3851-5. PubMed ID: 2509371
[TBL] [Abstract][Full Text] [Related]
3. Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06.
Pier GB; Koles NL; Meluleni G; Hatano K; Pollack M
Infect Immun; 1994 Apr; 62(4):1137-43. PubMed ID: 8132318
[TBL] [Abstract][Full Text] [Related]
4. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis.
Hemachandra S; Kamboj K; Copfer J; Pier G; Green LL; Schreiber JR
Infect Immun; 2001 Apr; 69(4):2223-9. PubMed ID: 11254577
[TBL] [Abstract][Full Text] [Related]
5. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial properties of Pseudomonas aeruginosa immunotype 1 lipopolysaccharide-specific monoclonal antibody (MAb) in a murine thigh infection model: combined effects of MAb and ceftazidime.
Akiyama M; Oishi K; Tao M; Matsumoto K; Pollack M
Microbiol Immunol; 2000; 44(8):629-35. PubMed ID: 11021392
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic and protective properties of a murine lipopolysaccharide-specific monoclonal antibody in experimental Pseudomonas aeruginosa pneumonia in mice.
Oishi K; Sonoda F; Miwa H; Tanaka H; Watanabe K; Matsumoto K; Pollack M
Microbiol Immunol; 1991; 35(12):1131-41. PubMed ID: 1808464
[TBL] [Abstract][Full Text] [Related]
9. Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa.
Collins MS; Ladehoff DK; Mehton NS; Noonan JS
FEMS Microbiol Immunol; 1990 Dec; 2(5-6):263-8. PubMed ID: 2127368
[TBL] [Abstract][Full Text] [Related]
10. O-polysaccharide-protein conjugates induce high levels of specific antibodies to Pseudomonas aeruginosa immunotype 3 lipopolysaccharide.
van de Wiel PA; Witvliet MH; Evenberg D; Derks HJ; Beuvery EC
Vaccine; 1987 Mar; 5(1):33-8. PubMed ID: 2437718
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies as probes to examine serotype-specific and cross-reactive epitopes of lipopolysaccharides from serotypes O2, O5, and O16 of Pseudomonas aeruginosa.
Lam JS; Handelsman MY; Chivers TR; MacDonald LA
J Bacteriol; 1992 Apr; 174(7):2178-84. PubMed ID: 1372599
[TBL] [Abstract][Full Text] [Related]
12. X-linked immunodeficient mice as a model for testing the protective efficacy of monoclonal antibodies against Pseudomonas aeruginosa.
Zweerink HJ; Gammon MC; Hutchison CF; Jackson JJ; Pier GB; Puckett JM; Sewell TJ; Sigal NH
Infect Immun; 1988 May; 56(5):1209-14. PubMed ID: 3128480
[TBL] [Abstract][Full Text] [Related]
13. Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa.
Schreiber JR; Patawaran M; Tosi M; Lennon J; Pier GB
J Immunol; 1990 Feb; 144(3):1023-9. PubMed ID: 2104908
[TBL] [Abstract][Full Text] [Related]
14. Protection of immunosuppressed mice against infection with Pseudomonas aeruginosa by recombinant P. aeruginosa lipoprotein I and lipoprotein I-specific monoclonal antibodies.
Finke M; Muth G; Reichhelm T; Thoma M; Duchêne M; Hungerer KD; Domdey H; von Specht BU
Infect Immun; 1991 Apr; 59(4):1251-4. PubMed ID: 1706316
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies that distinguish inner core, outer core, and lipid A regions of Pseudomonas aeruginosa lipopolysaccharide.
de Kievit TR; Lam JS
J Bacteriol; 1994 Dec; 176(23):7129-39. PubMed ID: 7525538
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo functional activities of monoclonal antibodies reactive with Pseudomonas aeruginosa serogroup 6 lipopolysaccharides.
Pollack M; Tao M; Akiyama M; Pier GB; Koles NL
Antibiot Chemother (1971); 1991; 44():163-71. PubMed ID: 1801635
[No Abstract] [Full Text] [Related]
17. Protection against infection with Pseudomonas aeruginosa by passive transfer of monoclonal antibodies to lipopolysaccharides and outer membrane proteins.
Sawada S; Suzuki M; Kawamura T; Fujinaga S; Masuho Y; Tomibe K
J Infect Dis; 1984 Oct; 150(4):570-6. PubMed ID: 6436393
[TBL] [Abstract][Full Text] [Related]
18. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate).
Hatano K; Goldberg JB; Pier GB
Infect Immun; 1995 Jan; 63(1):21-6. PubMed ID: 7528730
[TBL] [Abstract][Full Text] [Related]
19. Variable region-identical monoclonal antibodies of different IgG subclass directed to Pseudomonas aeruginosa lipopolysaccharide O-specific side chain function differently.
Schreiber JR; Cooper LJ; Diehn S; Dahlhauser PA; Tosi MF; Glass DD; Patawaran M; Greenspan NS
J Infect Dis; 1993 Jan; 167(1):221-6. PubMed ID: 8418172
[TBL] [Abstract][Full Text] [Related]
20. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
